The current PE ratio for Medtronic stock as of Jun 3, 2026 is 21.65. This is calculated based on the TTM EPS of $3.6 and the stock price of $77.95 per share. The PE ratio marks a decrease of 15% from its last 4 quarters average of 25.5.
The average historical PE ratio of Medtronic for the last ten years is 31.08. The current P/E ratio of 21.65 is 30% lower than the historical average. Looking back at the last ten years, MDT's PE ratio peaked in the Oct 2018 quarter at 53.74, when the price was $89.75 and the EPS was $1.67. The lowest point was in the Oct 2017 quarter, when it reached 22.03 with a price of $81.3 and an EPS of $3.69.
Maximum annual increase: 75.59% in 2021
Maximum annual decrease: -43.03% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 23.18 | -19.49% | $84.16 | $3.63 |
| 2024 | 28.79 | -10.42% | $79.74 | $2.77 |
| 2023 | 32.14 | 15.49% | $90.95 | $2.83 |
| 2022 | 27.83 | -43.03% | $104.36 | $3.75 |
| 2021 | 48.85 | 75.59% | $130.92 | $2.68 |
| 2020 | 27.82 | 9.57% | $99.3 | $3.57 |
| 2019 | 25.39 | -28.48% | $87.35 | $3.44 |
| 2018 | 35.5 | 24.74% | $81.29 | $2.29 |
| 2017 | 28.46 | -9.74% | $83.09 | $2.92 |
| 2016 | 31.53 | -0.88% | $79.15 | $2.51 |
| 2015 | 31.81 | 67.25% | $77.61 | $2.44 |
| 2014 | 19.02 | 39.44% | $58.21 | $3.06 |
| 2013 | 13.64 | 24.11% | $46.36 | $3.4 |
| 2012 | 10.99 | -24.47% | $37.69 | $3.43 |
| 2011 | 14.55 | -6.73% | $41.75 | $2.87 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jan 2026 | 28.02 | 11.28% | $100.88 | $3.6 |
| Oct 2025 | 25.18 | -1.37% | $93.67 | $3.72 |
| Jul 2025 | 25.53 | 10.14% | $92.94 | $3.64 |
| Apr 2025 | 23.18 | -14.94% | $84.16 | $3.63 |
| Jan 2025 | 27.25 | -1.02% | $90.19 | $3.31 |
| Oct 2024 | 27.53 | 4.24% | $90.59 | $3.29 |
| Jul 2024 | 26.41 | -8.27% | $78.7 | $2.98 |
| Apr 2024 | 28.79 | 4.81% | $79.74 | $2.77 |
| Jan 2024 | 27.47 | 21.87% | $86.54 | $3.15 |
| Oct 2023 | 22.54 | -30.52% | $69.43 | $3.08 |
| Jul 2023 | 32.44 | 0.93% | $88.25 | $2.72 |
| Apr 2023 | 32.14 | 18.69% | $90.95 | $2.83 |
| Jan 2023 | 27.08 | 0.74% | $82.58 | $3.05 |
| Oct 2022 | 26.88 | 12.7% | $86.82 | $3.23 |
| Jul 2022 | 23.85 | -14.3% | $92.52 | $3.88 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
MDT's current PE ratio is lower than its 3, 5 and 10-year averages.
With a price to earnings (P/E) of 21.65, MDT ranks lower than the Healthcare sector, the industry and its peers average. In comparison with the Healthcare sector average of 23.02, Medtronic's price to earnings (P/E) is 6% lower.
MDT's PE ratio stands lower than its peer stocks JNJ and ABT, but it is higher than BSX's and CNMD's. Medtronic's current PE ratio of 21.65 is lower than the average of its peers, which is 27.92.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CNMD CONMED Corp | 19.78 | $1.05B |
| BSX Boston Scientific Corp | 20.16 | $72.22B |
| MDT Medtronic plc | 22.55 | $104.21B |
| ABT Abbott Laboratories | 25.13 | $157.11B |
| JNJ Johnson & Johnson | 26.08 | $548.17B |
| SYK Stryker Corp | 34.23 | $114.67B |
| EW Edwards Lifesciences Corp | 46.26 | $50.35B |
| BAX Baxter International Inc | N/A | $9.86B |
| ACH Accendra Health Inc. | N/A | $208.69M |
| IART Integra Lifesciences Holdings Corp | N/A | $1.33B |
MDT stock has a price to earnings ratio of 21.65 as of Jun 3, 2026.
Over the last 3 years, the average price to earnings ratio for MDT stock is 26.76.
Over the last 5 years, the average price to earnings ratio for MDT stock is 28.44.
The highest quarterly PE ratio in the last ten years has been 53.74 and it was in the Oct 2018 quarter.
The current PE ratio of MDT is 30% lower than the 10-year historical average.
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Jun 3, 2026), Medtronic's share price is $77.95. The company's earnings per share for the trailing twelve months (TTM) ending Jan 2026 is $3.6. Therefore, Medtronic's PE ratio for today is 21.65. PE RATIO(21.65) = STOCK PRICE($77.95) / TTM EPS($3.6)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.